Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of an Intensive Tele-Tobacco Cessation Program Compared With Standard Smoking Cessation Support in Participants of the French IMPULSION Lung Cancer Screening Program (PROMETHEE)

NCT07921719 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07921719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of an Intensive Tele-Tobacco Cessation Program Compared With Standard Smoking Cessation Support in Participants of the French IMPULSION Lung Cancer Screening Program (PROMETHEE)
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
January 31, 2030
Enrollment
5,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer screening, smoking cessation

Arms

As registered; 2 arms.

  • PROMETHEE Cohort PROMETHEE Cohort

    Participants enrolled in IMPULSION and referred to the PROMETHEE tele-tobacco platform. The pathway includes facilitated access to smoking cessation specialists, up to four follow-up teleconsultations, and systematic consideration of pharmacological cessation treatment.

  • Control Cohort Control Cohort

    Matched IMPULSION participants receiving standard smoking cessation support according to local resources and the routine IMPULSION program

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Self-reported Smoking Cessation at 12 Months 12 months

    Proportion of participants reporting smoking cessation 12 months after inclusion through the IMPULSION electronic follow-up questionnaire.

Lead sponsor's other trials

Hospices Civils de Lyon, most recent start first.